Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renuka Iyer

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|October 6, 2010
Sandostatin desensitization--a strategy useful for patients with carcinoid tumors, intolerant to sandostatinSanjay Vinjamaram, Renuka Iyer
Expert Opinion on Pharmacotherapy|January 22, 2010
A review of erlotinib--an oral, selective epidermal growth factor receptor tyrosine kinase inhibitorRenuka Iyer, Anubha Bharthuar
Journal of Gastrointestinal Oncology|March 23, 2018
Immunomodulation in hepatocellular cancerSunyoung Lee, Matthew Loecher, Renuka Iyer
Journal of Gastrointestinal Oncology|August 2, 2014
Quality of life and hepatocellular carcinomaShipra Gandhi, Sapna Khubchandani, Renuka Iyer
Cancers|December 15, 2019
Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future ImplicationsMedhavi Gupta, Renuka Iyer, Christos Fountzilas
Journal of Carcinogenesis|April 17, 2014
Targeted therapy in gastrointestinal malignanciesRavi Chhatrala, Yasmin Thanavala, Renuka Iyer
Biometrical Journal. Biometrische Zeitschrift|December 17, 2009
Exact tests using two correlated binomial variables in contemporary cancer clinical trialsJihnhee Yu, James L Kepner, Renuka Iyer
Cell Reports. Medicine|August 31, 2023
The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerabilityArya Mariam Roy, Renuka Iyer, Sayan Chakraborty
Advances in Cancer Research|February 13, 2021
Immunotherapy in hepatocellular cancerChristos Fountzilas, Rachel Evans, Sabah Alaklabi, et al.
Expert Opinion on Pharmacotherapy|July 1, 2010
Sorafenib: a clinical and pharmacologic reviewRenuka Iyer, Gerald Fetterly, Amit Lugade, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|October 6, 2010
Sandostatin desensitization--a strategy useful for patients with carcinoid tumors, intolerant to sandostatinSanjay Vinjamaram, Renuka Iyer
Expert Opinion on Pharmacotherapy|January 22, 2010
A review of erlotinib--an oral, selective epidermal growth factor receptor tyrosine kinase inhibitorRenuka Iyer, Anubha Bharthuar
Journal of Gastrointestinal Oncology|March 23, 2018
Immunomodulation in hepatocellular cancerSunyoung Lee, Matthew Loecher, Renuka Iyer
Journal of Gastrointestinal Oncology|August 2, 2014
Quality of life and hepatocellular carcinomaShipra Gandhi, Sapna Khubchandani, Renuka Iyer
Cancers|December 15, 2019
Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future ImplicationsMedhavi Gupta, Renuka Iyer, Christos Fountzilas
Journal of Carcinogenesis|April 17, 2014
Targeted therapy in gastrointestinal malignanciesRavi Chhatrala, Yasmin Thanavala, Renuka Iyer
Biometrical Journal. Biometrische Zeitschrift|December 17, 2009
Exact tests using two correlated binomial variables in contemporary cancer clinical trialsJihnhee Yu, James L Kepner, Renuka Iyer
Cell Reports. Medicine|August 31, 2023
The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerabilityArya Mariam Roy, Renuka Iyer, Sayan Chakraborty
Advances in Cancer Research|February 13, 2021
Immunotherapy in hepatocellular cancerChristos Fountzilas, Rachel Evans, Sabah Alaklabi, et al.
Expert Opinion on Pharmacotherapy|July 1, 2010
Sorafenib: a clinical and pharmacologic reviewRenuka Iyer, Gerald Fetterly, Amit Lugade, et al.
Pageof 10